Skip to Content

3 Results Found

  • Article
  • Open Access
8 Citations
2,845 Views
18 Pages

Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome

  • Mikhail E. Blokhin,
  • Sergey O. Kuranov,
  • Mikhail V. Khvostov,
  • Vladislav V. Fomenko and ,
  • Olga A. Luzina,
  • Natalia A. Zhukova,
  • Cham Elhajjar,
  • Tatiana G. Tolstikova and
  • Nariman F. Salakhutdinov
  • + 4 authors+ 0 author

Metabolic syndrome is a complex of abnormalities involving impaired glucose and lipid metabolism, which needs effective pharmacotherapy. One way to reduce lipid and glucose levels associated with this pathology is the simultaneous activation of nucle...

(This article belongs to the Special Issue Bioactive Compounds of Natural Products on Metabolic Disorders and Complications)
  • Review
  • Open Access
9 Citations
3,564 Views
26 Pages

Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment

  • Hung Thai Vu,
  • Vien Duc Nguyen,
  • Hiroko Ikenaga and
  • Tsutomu Matsubara

Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) is a major disease worldwide whose effective treatment is challenging. Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamil...

(This article belongs to the Section Cell Biology and Pathology)
  • Article
  • Open Access
3,327 Views
17 Pages

Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome

  • Mikhail E. Blokhin,
  • Sergey A. Borisov,
  • Mariia A. Gromova,
  • Yulia V. Meshkova and ,
  • Nataliya A. Zhukova,
  • Sophia V. Nikonova,
  • Igor P. Zhurakovsky,
  • Olga A. Luzina,
  • Mikhail V. Khvostov and
  • Nariman F. Salakhutdinov
  • + 6 authors+ 1 author

5 September 2025

Metabolic syndrome is characterized by a group of metabolic disorders that can lead to the development of cardiovascular diseases, obesity and type 2 diabetes mellitus (T2DM). Nowadays, there are several groups of drugs for the treatment of T2DM, but...